McKinsey Faces Block on FDA Contracts Amid Opioid Investigation

The Food and Drug Administration won’t contract with McKinsey & Company while lawmakers investigate the consultancy’s work with opioid makers and alleged conflicts of interest, an agency leader said Tuesday.

“We anticipate that further contracts will not be issued pending the outcome of the investigations,” FDA Center for Drug Evaluation and Research Director Patrizia Cavazzoni said during a hearing of the Senate Committee on Health, Education, Labor and Pensions. Cavazzoni also said the FDA currently doesn’t have any contracts with the consultancy.

The comments come as the House Oversight Committee gears up to grill McKinsey’s global manager Bob Sternfels on ...